The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Coronary Microvascular Dysfunction, Microvascular Angina, and Treatment Strategies
Open accessAbstract
Angina without coronary artery disease (CAD) has substantial morbidity and is present in 10–30% of patients undergoing angiography. Coronary microvascular dysfunction (CMD) is present in 50–65% of these patients. The optimal treatment of this cohort is undefined. We performed a systematic review to evaluate treatment strategies for objectively defined CMD in the absence of CAD. We included studies assessing therapy in human subjects with angina and coronary flow reserve (CFR) or myocardial perfusion reserve (MPR) <2.5 by positron emission tomography (PET), cardiac magnetic resonance imaging (CMR), dilution methods, or intracoronary Doppler in the absence of coronary artery stenosis ≥50% or structural heart disease. Only 8 articles met strict inclusion criteria. The articles were heterogeneous, using different treatments, end-points, and definitions of CMD. Small sample sizes severely limit the power of these studies, with an average of 11 patients per analysis. Studies evaluating, sildenafil, quinapril, estrogen, and transcutaneous electrical nerve stimulation (TENS) application demonstrated benefits in their respective endpoints. No benefit was found with L-arginine, doxazosin, pravastatin, and diltiazem. Our systematic review highlights that there is little data to support therapies for CMD. We assess the data meeting rigorous inclusion criteria and review the related but excluded literature. We additionally describe the next steps needed to address this research gap, including a standardized definition of CMD, routine assessment of CMD in studies of chest pain without obstructive CAD, and specific therapy assessment in the population with confirmed CMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2466 · Cited by 2,739 · cited 2×
“Nitric oxide (NO) is a key player in endothelium-dependent mediation of coronary microvasculature tone through the activation of a guanylate cyclase signaling pathway preventing smooth muscle activation (54).”
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction
Suwaidi, J. A., Hamasaki, S., Higano, S. T., Nishimura, R. A., Holmes, D. R., & Lerman, A. (2000) · Circulation · doi:10.1161/01.cir.101.9.948 · Cited by 2,043
Coronary Microvascular Dysfunction
Camici, P. G., & Crea, F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra061889 · Cited by 1,605
Coronary Microvascular Dysfunction
Crea, F., Lanza, G. A., & Camici, P. G. (2014) · Springer eBooks · doi:10.1007/978-88-470-5367-0 · Cited by 1,287
Effects of coronary stenoses on coronary flow reserve and resistance
Gould, K. L., & Lipscomb, K. (1974) · The American Journal of Cardiology · doi:10.1016/0002-9149(74)90092-7 · Cited by 882
Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve
Murthy, V. L., Naya, M., Foster, C. R., Hainer, J., Gaber, M., Di Carli, G., Blankstein, R., Dorbala, S., Sitek, A., Pencina, M. J., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.050427 · Cited by 850
Pepine, C. J., Anderson, R. D., Sharaf, B. L., Reis, S. E., Smith, K. M., Handberg, E. M., Johnson, B. D., Sopko, G., & Bairey Merz, C. N. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.054 · Cited by 805
Coronary microvascular dysfunction: an update
Crea, F., Camici, P. G., & Bairey Merz, C. N. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht513 · Cited by 782
Long-Term Prognostic Value of 13N-Ammonia Myocardial Perfusion Positron Emission Tomography
Herzog, B. A., Husmann, L., Valenta, I., Gaemperli, O., Siegrist, P. T., Tay, F. M., Burkhard, N., Wyss, C. A., & Kaufmann, P. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.069 · Cited by 616
Angina With “Normal” Coronary Arteries: A Changing Philosophy
Bugiardini, R., & Bairey Merz, C. N. (2005) · JAMA · doi:10.1001/jama.293.4.477 · Cited by 519
Cited by
Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options
Taqueti, V. R., & Di Carli, M. F. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.042 · Cited by 769
Bairey Merz, C. N., Pepine, C. J., Walsh, M. N., Fleg, J. L., Camici, P. G., Chilian, W. M., Clayton, J. A., Cooper, L. S., Crea, F., Di Carli, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024534 · Cited by 748
Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease
Horton, W. B., & Barrett, E. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa025 · Cited by 424
Kaski, J.-C., Crea, F., Gersh, B. J., & Camici, P. G. (2018) · Circulation · doi:10.1161/circulationaha.118.031373 · Cited by 340
Coronary Microvascular Dysfunction
Vancheri, F., Longo, G., Vancheri, S., & Henein, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092880 · Cited by 321
Metadata
- Authors
- Marinescu, M. A., Löffler, A. I., Ouellette, M., Smith, L., Kramer, C. M., & Bourque, J. M.
- Venue
- JACC: Cardiovascular Imaging
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 8
- Issue
- 2
- Pages
- 210-220
- ISSN
- 1876-7591 (ISSN-L)
- 1936-878X
- OpenAlex
- W2394828260
- Cited by
- 302
- References
- 56
- FWCI
- 19.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Coronary Microvascular Dysfunction, Microvascular Angina, and Treatment Strategies. https://app.cochat.ai/papers/10.1016/j.jcmg.2014.12.008
- The paper
- Marinescu, M. A., Löffler, A. I., Ouellette, M., Smith, L., Kramer, C. M., & Bourque, J. M. (2015). Coronary Microvascular Dysfunction, Microvascular Angina, and Treatment Strategies. JACC: Cardiovascular Imaging. https://doi.org/10.1016/j.jcmg.2014.12.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.